Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
IRBESARTAN | 75MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70366 |
IRBESARTAN | 150MG | TABLET | Resolved | 2018-12-21 | 2019-02-22 | 70369 |
AVAPRO | 75MG | TABLET | Resolved | 2018-11-29 | 2019-02-27 | 68058 |
AVALIDE | 12.5MG 150MG | TABLET | Resolved | 2018-12-20 | 2019-02-27 | 70230 |
AVALIDE | 12.5MG 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-02 | 75166 |
IRBESARTAN-HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-01-16 | 2019-03-05 | 72434 |
AVAPRO | 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-29 | 75171 |
IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Resolved | 2019-01-28 | 2019-04-09 | 73693 |
TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68619 |
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2018-12-04 | 2019-04-11 | 68622 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65068 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65071 | ||
ACT IRBESARTAN/HCT | Discontinued | 2018-10-19 | 2018-10-19 | 65074 | ||
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |